Life Science Nation Newsletter  |  November 27, 2014  |  Issue 90

       The LSN Story  |  Investor Platform  |  Company Platform  |  RESI Conference  |  Fundraising Accelerator
Life Science Investor Mandates (Nov. 20 - Nov. 26)

Seeks AgBio and Sustainable Bio Opportunities

Seeks Healthcare IT Opportunities

Invests In Oncology, Cardiovascular, Anti-infectives, CNS/pain, and Women's Health
Investing In Innovative Early-Stage Medtech
Interested in Orphan Drugs
Seeks Medical Devices, Diagnostics, Lab Equipment, and Healthcare IT
Looking At Healthcare Technology for Emerging Markets 
Funds Diagnostics, Vaccines and Women's Health
Invests in Drug Development, Diagnostics, and Medical Devices
Investing In Medtech, Healthcare IT, and Biotech R&D Services
Life Science Nation and FreeMind Group Align In San Francisco for Early Stage Fundraising Executives 

By Dennis Ford, Founder & CEO, LSN 


Today, Life Science Nation (LSN) accelerates the funding of early stage life science firms via a sourcing platform for private investment, making CEOs more efficient in their capital raising efforts. The FreeMind Group (FMG) specializes in assisting life science organizations secure non-dilutive funding from US Federal Agencies and Private Foundations. LSN and FMG are experts in early stage private and non-dilutive funding respectively, and this complementary expertise fully supports the early stage financing needs of life science entrepreneurs.  As both of these financing sources are vital to early-stage financing, CEOs benefit from understanding both domains: LSN's 10 categories of private early stage and FMG's governmental non-dilutive funding.


LSN and FMG have been working side by side for years, and recently saw that combining both pools of attendees at their respective conferences could transform each from a one-day event into a two-day conference offering dynamic partnering and compelling financing content to the early-stage CEOs visiting San Francisco during the JP Morgan Healthcare Conference...


Read More

A Thanksgiving Mandate Cornucopia

By Lucy Parkinson, Senior Research Manager, LSN 


Here at LSN, we're getting ready to go home for Thanksgiving.  But first, we'd like to thank all our readers, supporters and friends across the global life science industry.  We wouldn't be here without you.

In the spirit of the season, LSN Research welcomes you to the table to share the mandates we've gathered from our recent conversations with investors across the world. This cornucopia of investors are from 6 different nations, and cover every niche of the life science sector - from agriculture to therapeutics to devices to healthcare IT.


Click on the mandates in the sidebar to see what's cooking in the rest of the world.


LSN Video Gallery
RESI Conference 2014, Fenway Park
RESI Conference 2014, Fenway Park
RESI 3 Family Office Panel
RESI 3 Family Office Panel
RESI 3 Outbound Fundraising Panel
RESI 3 Outbound Fundraising Panel
RESI 3 Corporate Venture Capital Panel
RESI 3 Corporate Venture Capital Panel
The Life Science Executive's Fundraising Manifesto
RESI Conference 2014 Spring
RESI Conference 2014 Spring
Investor Platform Demo
LSN Investor Platform Demo
Company Platform Demo
LSN Company Platform Demo

Address: 9B Hamilton Place, Boston, MA, 02108, USA

Phone: +1 (617) 600-0668


follow us: Follow us on Twitter View our profile on LinkedIn  

Michael Quigley, Director of Research, LSN
Nono Hu, Senior Manager, Branding & Messaging, LSN